Evista completes divestiture of KaVo dental treatment, instrument business

Envista has completed the divestiture of its KaVo dental treatment unit and instrument business, the Carmel, Ind.-based dental supply company said Jan. 3.

The company said it received $317.3 million in cash as of closing and expects to receive additional payouts in the first half of 2022 to reach a total of $383 million.

Envista said it will use the funds for future acquisitions and internal investments. 

Envista's imaging business, which uses select KaVo products, will remain under Envista as part of its equipment and consumables segment.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

Featured Podcast